Erik Harris's Net Worth
$6.06 Million
Who is Erik Harris?
Erik Harris has an estimated net worth of $6.06 Million. This is based on reported shares across multiple companies, which include Ultragenyx Pharmaceutical Inc., and Denali Therapeutics Inc..
SEC CIK
Erik Harris's CIK is 0001780113
Past Insider Trading and Trends
2023 was Erik Harris's most active year for acquiring shares with 5 total transactions. Erik Harris's most active month to acquire stocks was the month of February. 2021 was Erik Harris's most active year for disposing of shares, totalling 9 transactions. Erik Harris's most active month to dispose stocks was the month of February. 2023 saw Erik Harris paying a total of $0.00 for 80,928 shares, this is the most they've acquired in one year. In 2021 Erik Harris cashed out on 5,960 shares for a total of $714,405.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $55.24
EVP & Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.65% | 15.59K |
$53.76 | -$256,327.68 | 138.8K |
Mar 1
| |||
Form 4
| -10.47% | -6.00K |
$37.96 | -$227,760.00 | 51.28K |
Sep 5
| |||
Form 4
| -0.53% | -305.00 |
$48.20 | -$14,701.00 | 57.28K |
Jun 19
| |||
Form 4
| +21.61% | 21K |
$45.25 | -$165,796.00 | 118.17K |
Mar 1
| |||
Form 4
| -0.81% | -295.00 |
$54.78 | -$16,160.10 | 36.16K |
Jun 19
| |||
Form 4
| +45.09% | 11.29K |
$66.62 | -$180,740.06 | 36.32K |
Mar 1
| |||
Form 4
| -1.20% | -303.00 |
$81.14 | -$24,585.42 | 25.03K |
Oct 14
| |||
Form 4
| -1.46% | -375.00 |
$91.53 | -$34,323.75 | 25.33K |
Jul 6
| |||
Form 4
| -3.78% | -1.01K |
$94.82 | -$95,670.43 | 25.71K |
Scheduled
|
Jun 19 - Jun 21
| ||
Form 4
| -2.55% | -700.00 |
$113.67 | -$79,572.07 | 26.72K |
Scheduled
|
May 6 - May 7
| ||
Form 4
| -1.42% | -396.00 |
$104.28 | -$41,294.88 | 27.42K |
Scheduled
|
Apr 20
| ||
Form 4
| +33.37% | 6.96K |
$138.17 | -$438,959.02 | 27.81K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
| -10.77% | -2.52K |
$74.69 | -$187,920.04 | 20.85K |
Jun 3
| |||
Form 4
| -0.93% | -220.00 |
$88.00 | -$19,360.00 | 23.37K |
Oct 14
| |||
Form 4
| -1.09% | -260.00 |
$86.75 | -$22,555.00 | 23.59K |
Jul 6
| |||
Form 4
| -1.25% | -303.00 |
$78.22 | -$23,700.66 | 23.85K |
Jun 19
| |||
Form 4
| -0.86% | -209.00 |
$66.26 | -$13,848.34 | 24.15K |
May 6
| |||
Form 4
| -0.85% | -210.00 |
$58.57 | -$12,299.70 | 24.36K |
Apr 19
| |||
Form 4
| +71.72% | 10.26K |
$56.08 | -$46,209.92 | 24.57K |
Mar 1
| |||
Form 4
| +9.22% | 1.21K |
—
|
—
| 14.31K |
Oct 14
| |||
Form 4
| -1.95% | -260.00 |
$59.51 | -$15,472.60 | 13.1K |
Jul 6
| |||
Form 4
| +35.49% | 3.5K |
—
|
—
| 13.36K |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Denali Therapeutics Inc. (DNLI) Snapshot price: $25.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +53.83% | 5.97K |
—
|
—
| 17.05K |
May 31
| |||
Form 4
| +61.38% | 4.22K |
—
|
—
| 11.09K |
Jun 1
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 6.87K |
—
|
—
| 6.87K |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||